EngageME investigates the use of humanoid robots (for example, NAO) in autism therapy for children with ASC. This technology builds upon state-of-the-art machine learning, bringing novel personalized and culture-tailored models for automated measurement of affect and engagement. What’s specific to this project is that we devised robot perception that uses personalized machine learning to adapt its interpretations of observed affective states, such as valence (pleasure-displeasure continuum) and arousal (alertness), and engagement in the task, to each child.
Robots have great potential to facilitate future therapies for children on the autism spectrum. However, existing robots lack the ability to automatically perceive and respond to human affect, which is necessary for establishing and maintaining engaging interactions. Moreover, their inference challenge is made harder by the fact that many individuals with autism have atypical and unusually diverse styles of expressing their affective-cognitive states. To tackle the heterogeneity in behavioral cues of children with autism, we use the latest advances in deep learning to formulate a personalized machine learning (ML) framework for automatic perception of the children’s affective states and engagement during robot-assisted autism therapy. The key to our approach is a novel shift from the traditional ML paradigm; instead of using 'one-size-fits-all' ML models, our personalized ML framework is optimized for each child by leveraging relevant contextual information (demographics and behavioral assessment scores) and individual characteristics of each child. We designed and evaluated this framework using a dataset of multi-modal audio, video and autonomic physiology data of 35 children with autism (age 3-13) and from 2 cultures (Asia and Europe), participating in a 25-minute child-robot interaction (~500k datapoints). Our experiments confirm the feasibility of the robot perception of affect and engagement, showing clear improvements due to the model personalization. The proposed approach has potential to improve existing therapies for autism by offering more efficient monitoring and summarization of the therapy progress.
Oggi Rudovic (please get in touch via email: firstname.lastname@example.org)